Founders Fund

NewLimit aging

NewLimit Raises $40M in Bid To Reverse Aging

NewLimit, a biotech company, is on a mission to reverse the features of aging by manipulating cell age without changing cell type.

Tempo Announces $60M in New Funding to Expand Its Pioneering Home Fitness System

Tempo, the first smart gym that delivers the guidance of a personal trainer with A.I., and the only one that provides live form feedback and includes real weights